MolecularMD has received certification of its Next Generation Sequencing (NGS) clinical lab in Cambridge, MA under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. CLIA establishes quality standards for lab testing to help ensure accuracy, reliability and timeliness of test results, regardless of where the test is performed.    The Cambridge lab provides custom solutions for NGS-based companion diagnostics to support early stage and pivotal clinical studies. The company has develop...